Reference

1. Dr. Christine King, Thyroid Hormones and Equine Metabolic Syndrome. American Journal of Veterinary Research. 2005: 66(6): 1025-1031.
2. Dumont, J. et al. Ontogeny, Anatomy, Metabolism and Physiology of the Thyroid. Thyroid Disease Manager. Available at: http://www/. Thyroidmanager. Org/chapter/ontogeny-anatomy-metabolismand-physiology-of-the-thyroid (2011).
3. De Leo, S., Lee, S. Y. & Braverman, L. E. Hyperthyroidism. Lancet 388, 906 918, doi:10.1016/s0140-6736(16)00278-6 (2016).
4. Chaker, L., Bianco, A. C., Jonklaas, J. & Peeters, R. P. Hypothyroidism. Lancet, doi:10.1016/s0140-6736(17)30703-1 (2017).
5. Rice, S. P., Boregowda, K., Williams, M. T., Morris,  G. C. & Okosieme, O. E. A Welshsparing dysphasia. Lancet 382, 1608, doi:10.1016/s01406736(13)61837-1 (2013).
6. Taylor, P. N. et al. Weekly Intramuscular Injection of Levothyroxine following Myxoedema: A Practical Solution to an Old Crisis. Case reports in endocrinology 2015, 169194, doi:10.1155/2015/169194 (2015).
7. Gregory A. Brent: Environmental Exposures and Autoimmune Thyroid Disease. Volume 20:2010: 755.
8. Thyroid Guidelines Committee, AACE clinical practice guidelines Endocr Pract Vol No 8: 2002:458.
9. Ryan Drum, thyroid problems. Herbs and supplements of thyroid imbalance, 2000.
10. Thyroid Guidelines Committee, AACE clinical practice guidelines for sub clinical hypothyroidism Endocr Pract. Vol No 8: 2002:459.
11. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.
12. AACE Thyroid Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract . 2002;8:458-469.
13. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:26462655.
14. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012;86:244–51.
15. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390:1550–62.
16. Watt T, Hegedus L, Rasmussen AK, et al. Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives. Thyroid. 2007;17:647–54.
17. Guglielmi R, Grimaldi F, Negro R, et al. Shift from levothyroxine tablets to liquid formulation at breakfast improves quality of life of hypothyroid patients. Endocr Metab Immune Disord Drug Targets. 2018;18:235–40.
18. Malaty W. Primary hypothyroidism. 2017. https:// bestpractice.bmj.com/topics/enus/535/pdf/535.pdf. Accessed 4 Jan 2017.
19. Abdalla SM, Bianco AC. Defending plasma T3 is a biological priority. Clin Endocrinol. 2014;81:633–41.
20. Larsen PR, Silva JE, Kaplan MM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev. 1981;2:87–102.
21. Harel L, Prais D, Uziel Y, et al. Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis. J Rheumatol. 2006;33:164-166.
22. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA . 1995;273:808-812.
23. Elmor R, Sandulli W, Carter CA. The economic impact of changing levothyroxine formulations in difficult-to-treat hypothyroid patients: an evidence-based model. Pharmacoeconomics. 2017;2:1–10.
24. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228–38.
25. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 5483–88.
26. MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should b McDermott e treated. J Clin Endocrinol Metab 2001; 86: 4585–90.
27. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526–34.
28. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76–131. Epub 2007/11/10. Doi: 10.1210/er.2006–0043. PubMed PMID: 17991805.
29. Diez JJ, Iglesias P, Burman KD. Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 2005; 90: 4124–27.
30. Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR. High frequency of and factors associated with thyroid hormoneover-replacement and under-replacement in men and women aged.
31. Taylor PN, Iqbal A, Minassian C, etal. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks. JAMAInternMed.2014;174(1):32-39. Doi:10.1001/ jamainternmed.2013.11312.
32. Korevaar TIM, Medici M, Visser TJ, et al. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol 2017;13(10): 610–22.
33. Taylor PN, Zouras S, Min T, et al. Thyroid screening in early pregnancy: pros and cons. Front Endocrinol (Lausanne) 2018;9:626.
34. C E Anderson, K M McLaren. Best practice in thyroid pathology J Clin Pathol .2003: 56:401–402. 
35. Schoenmakers N, Alatzoglou KS, Chatterjee VK, Dattani MT. Recent advances in central congenital hypothyroidism. The Journal of Endocrinology. 2015;227:R51-R71.
36. Grant DB, Smith I, Fuggle PW, Tokar S, Chapple J: Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early clinical features. ArchDisChild 1992, 67(1):87-90.
37. Ford, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab 2014;28(2):175–87.
38. LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab 2007; 20:559-78.
39. Turnbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93.
40. Thyroid Guidelines Committee, AACE Thyroid guidelines for causes for hyperthyroidism. Endocr Pract. 2002:8: 458459. 
41. Levy EG. Thyroid disease in the elderly. Med Clin North Am 1991;75: 151-67.
42. Weetman AP. Graves’ disease. N Engl J Med 2000;343:1236-48.
43. Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med 2000;160:1067-71.
44. Thyroid Guidelines Committee, AACE clinical practice guidelines for symptoms of hyperthyroidism Endocr Pract Vol 8 No. 6 November/December 2002; 459.
45. De los Santos ET, Starich GH, Mazzaferri EL. Sensitivity, specificity, and cost-eff ectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 1989; 149: 526–32.
46. Harper MB, Mayeaux EJ Jr. Thyroid disease. In: Taylor RB. Family medicine: principles and practice. 6th ed. New York: Springer, 2003:1042-52. 16. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, et al. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. J Clin Endocrinol Metab 1996;81:2986-93.
47. American Academy of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-69.
48. Rivkees SA. The use of radioactive iodine in the management of hyperthyroidism in children. In: Current drug targets. Immune, endocrine and metabolic disorders. Vol 1. Boca Raton, Fla.: Bentham Science Publishers, 2001:255-64.
49. Alsanea O, Clark OH. Treatment of Graves’ disease: the advantages of surgery. Endocrinol Metab Clin North Am 2000;29:321-37.
50. Mitchell AL, Pearce SH. How should we treat patients with low serum thyrotropin concentrations? Clin Endocrinol (Oxf). 2010;72(3):292e296.
51. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343e1421.
52. Learoyd DL, Fung HY, McGregor AM. Postpartum thyroid dysfunction. Thyroid. 1992;2(1):73e80.
53. Thyroid Guidelines Committee. AACE clinical practice guidelines for diagnosis of Thyroid diseases. Endocr Pract 2002:8: 8:459.
54. Thyroid Guidelines Committee. AACE clinical practice guidelines for   evaluation &  treatment of thyroid. Endocr Pract 2002: 8: 460-464.
55. McKenzie JM, Zakarija M. The clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab 1989;69:1093–6.
56. Pe´ter F, Foley TP Jr. Hyperthyroxinemia. In: Hochberg Z, editor. Practical algorithms in pediatric endocrinology. 2nd edition. Basel: Karger; 2007. P. 92–3.